Exact Mass: 416.1238

Exact Mass Matches: 416.1238

Found 104 metabolites which its exact mass value is equals to given mass value 416.1238, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tenitramine

C10H20N6O12 (416.1139)

C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside]

2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzaldehyde

C18H24O11 (416.1319)

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is found in alcoholic beverages. 2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is isolated from Filipendula ulmaria (meadowsweet). Isolated from Filipendula ulmaria (meadowsweet). 2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is found in tea and alcoholic beverages.

Iophendylate

Ethyl 10-(2-iodophenyl)undecanoic acid

C19H29IO2 (416.1212)

Iophendylate is a mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization. Iophendylate is a myelographic oil-ester (U.S. Patent 2,348,231). Iophendylate, which was never shown to be safe, was initially introduced for use in small amounts (1-2cc) for locating spinal tumors. It next appeared on the world scene for high volume (12-15cc), routine use, in diagnosing disc herniations. A number of clinicians have published on the dangers of oil myelography. In 1942 Van Wagenen (a neurosurgical colleague of Warrens, at the University of Rochester) identified Iophendylate as causing chemical meningitis in 30 patients where space-displacing masses within the spinal canal were suspected.

(R)-3-[3-(4-Fluorophenylsulphonylamino)-1,2,3,4-tetrahydrocarbazol-9-yl]propionic acid

C21H21FN2O4S (416.1206)

Duvelisib

8-chloro-2-phenyl-3-{1-[(7H-purin-6-yl)amino]ethyl}-1,2-dihydroisoquinolin-1-one

C22H17ClN6O (416.1152)

1-(2-Chloro-4-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-propylurea

N-(2-Chloro-4-((6,7-dimethoxy-4-quinazolinyl)oxy)phenyl)-n-propylurea

C20H21ClN4O4 (416.1251)

alpinoside

C18H24O11 (416.1319)

O-Acetylgeniposidic acid

10-O-Acetylgeniposidic acid

C18H24O11 (416.1319)

Regaloside C

[(2S)-2-Hydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

Regaloside C is a natural product found in Lilium henryi, Lilium brownii, and other organisms with data available. Regaloside C is a glycerol glucoside isolated from the bulbs of?Lilium genus with anti-inflammatory activities. Regaloside C has cardiomyocyte protective activity by protecting the mitochondria in H2O2-induced heart H9C2 cells[1].

N,N-diformyldityrosine

C20H20N2O8 (416.122)

Nikkomycin M

C15H20N4O10 (416.1179)

4-[O-alpha-apiofuranosyl-(1->2)-beta-D-glucopyranosyloxy]benzaldehyde

C18H24O11 (416.1319)

15-O-deacetylrhaposerin|cebellin J

C19H25ClO8 (416.1238)

regaloside L

C18H24O11 (416.1319)

4-O-(3,4-Dihydroxycinnamoyl)-beta-D-(2R)-1-O-Glucopyranosylglycerol

C18H24O11 (416.1319)

1-O-beta-D-(3-caffeoyl)glucopyranosylglycerol

C18H24O11 (416.1319)

vernchinilide C

C19H25ClO8 (416.1238)

C14H24O14

C14H24O14 (416.1166)

Interruptin C

C25H20O6 (416.126)

C18H24O11

C18H24O11 (416.1319)

1-O-beta-D-(6-caffeoyl)glycopyranosylglycerol

C18H24O11 (416.1319)

beta-D-xylopyranosyl(1->2)-7-O-benzoyl-beta-D-glucopyranoside

C18H24O11 (416.1319)

Regaloside K

C18H24O11 (416.1319)

[(2S)-3-hydroxy-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate is a natural product found in Lilium mackliniae with data available.

2-[[2-amino-2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]pentanedioic acid

C15H20N4O10 (416.1179)

(7R)-8-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]chrysin

C25H20O6 (416.126)

(3Z)-6,7-dihydroxy-4-methoxy-3-(phenylmethylidene)-5-(3-phenylpropanoyl)-1-benzofuran-2(3H)-one|bractelactone

C25H20O6 (416.126)

(R)-3-[3-(4-Fluorophenylsulphonylamino)-1,2,3,4-tetrahydrocarbazol- 9-yl]propionic acid

C21H21FN2O4S (416.1206)

tm30089

C21H21FN2O4S (416.1206)

Zuclopenthixol sulfoxide

C22H25ClN2O2S (416.1325)

Iophendylate

C19H29IO2 (416.1212)

CAY10471

(+)-3-[[(4-fluorophenyl)sulfonyl]methylamino]-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid

C21H21FN2O4S (416.1206)

Ramatroban

3R-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid

C21H21FN2O4S (416.1206)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Spiraein (filipendula)

2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzaldehyde

C18H24O11 (416.1319)

2-(Methylthio)-4-(tributylstannyl)pyrimidine

C17H32N2SSn (416.1308)

2-Methylthio-5-(tributylstannyl)pyrimidine

C17H32N2SSn (416.1308)

KRN-633

VEGF receptor tyrosine kinase inhibitor III

C20H21ClN4O4 (416.1251)

Amosulalol hydrochloride

Benzenesulfonamide, 5-[1-hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methyl-, hydrochloride

C18H25ClN2O5S (416.1173)

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Bromerguride

C20H25BrN4O (416.1212)

MK-7246-D3

C21H21FN2O4S (416.1206)

Phosphonicacid, [(phenylamino)-4-pyridinylmethyl]-, diphenyl ester (9CI)

C24H21N2O3P (416.129)

Duvelisib

C22H17ClN6O (416.1152)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

3-[3-[(4-Fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid

C21H21FN2O4S (416.1206)

5-(Benzenesulfonyl)-4-(2,6-dimethylphenoxy)-2-phenylpyrimidine

C24H20N2O3S (416.1195)

2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide

C23H20N4O2S (416.1307)

4-Amino-2-[[4-amino-6-(4-fluoroanilino)-1,3,5-triazin-2-yl]methylthio]-5-pyrimidinecarboxylic acid ethyl ester

C17H17FN8O2S (416.1179)

N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-[(2-methyl-1-piperidinyl)sulfonyl]benzamide

C19H20N4O5S (416.1154)

N-(5-adenylyl)morpholine

C14H21N6O7P (416.1209)

An organic phosphoramidate obtained by formal condensation of the phosphate group of AMP with the amino group of L-morpholine.

[(4S,5R,6S,8S,10R)-10-[(S)-(2,4-dioxo-1H-pyrimidin-6-yl)-hydroxymethyl]-5-methyl-2,11-diaza-12-azoniatricyclo[6.3.1.04,12]dodec-1(12)-en-6-yl] hydrogen sulfate

C15H22N5O7S+ (416.124)

[(4S,5R,6S,8S,10R)-10-[(R)-(2,4-dioxo-1H-pyrimidin-6-yl)-hydroxymethyl]-5-methyl-2,11-diaza-12-azoniatricyclo[6.3.1.04,12]dodec-1(12)-en-6-yl] hydrogen sulfate

C15H22N5O7S+ (416.124)

4-(6-methoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-methoxy-5-(trifluoromethyl)phenyl]pyrimidin-2-amine

C19H15F3N6O2 (416.1209)

N-(1-isoquinolinyl)-4-[3-(trifluoromethyl)phenyl]-1-piperazinecarbothioamide

C21H19F3N4S (416.1282)

3-[[4-(2-Benzofuranyl)-2-thiazolyl]methyl]-2-[(dimethylamino)methyl]-4-quinazolinone

C23H20N4O2S (416.1307)

12-oxo-N-(4-phenyl-2-thiazolyl)-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazoline-3-carboxamide

C23H20N4O2S (416.1307)

Succinic acid, 2,2,3,3,4,4,5,5-octafluoropentyl 2-methylpent-3-yl ester

C15H20F8O4 (416.1234)

Dipyrromethane cofactor(4-)

C20H20N2O8-4 (416.122)

2-[(3S,6aR,8S,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aS,8R,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aR,8S,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aS,8S,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aS,8S,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aS,8R,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

tetraacetyl-N-azidoacetyl-D-mannosamine

C15H20N4O10 (416.1179)

[(S)-3-[[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-2-hydroxypropyl]beta-D-glucopyranoside

C18H24O11 (416.1319)

ethyl 10-(2-iodophenyl)undecanoate

C19H29IO2 (416.1212)

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside]

C18H24O11 (416.1319)

ST 18:3;O6;S

C18H24O9S (416.1141)

(8r,9r)-8-benzyl-5,8,9-trihydroxy-6-methyl-4-phenyl-9h-furo[2,3-h]chromen-2-one

C25H20O6 (416.126)

(2r)-1-hydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

(2s,3r,4s,5r,6s)-6-{[(2s,3s,4s,5s,6s,7r)-1,3,4,5,6,7-hexahydroxy-8-oxooctan-2-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C14H24O14 (416.1166)

1-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

3-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

10-O-acetylgeniposidic acid

C18H24O11 (416.1319)

{"Ingredient_id": "HBIN000178","Ingredient_name": "10-O-acetylgeniposidic acid","Alias": "NA","Ingredient_formula": "C18H24O11","Ingredient_Smile": "CC(=O)OCC1=CCC2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "416.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39936","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101996850","DrugBank_id": "NA"}